Introducing BMJ Medicine
BMJ 2021; 374 doi: https://doi.org/10.1136/bmj.n1883 (Published 28 July 2021) Cite this as: BMJ 2021;374:n1883
- Sophie Cook, editor in chief1,
- Emma Doble, patient partnership editor2,
- Kamran Abbasi, executive editor2,
- Claire Rawlinson, publisher3,
- Fiona Godlee, editor in chief2
- 1BMJ Medicine, London, UK
- 2The BMJ, London, UK
- 3BMJ Journals, London, UK
- Correspondence to: S Cook scook{at}bmj.com
The covid-19 pandemic has been accompanied by an explosion in scientific discourse across mainstream media, social media, preprint servers,1 and peer reviewed journals. Alongside the remarkable medical advances, we have witnessed a barrage of misinformation and bad science that has threatened public health and patient care. The hunger for timely and reliable medical information during the pandemic has reinforced the importance of robust journal processes in advancing knowledge and managing messages to maximise benefit and minimise harm. But despite rapid growth in the number of journals, the proportion that are professionally edited remains small.
With these things in mind, The BMJ will launch a new open access multispecialty journal, BMJ Medicine,2 in the last quarter of 2021.
Closely aligned with The BMJ, BMJ Medicine will provide an important space for high quality multidisciplinary discussion and debate for a broad international readership and will adopt the values, editorial standards, and author service for which The BMJ is renowned. It will offer a trusted open access home for multispecialty research, including research based …